Alterations of Central Liver Metabolism of Pediatric Patients with Non-Alcoholic Fatty Liver Disease
Authors:
- Nikolaus BerndtNikolaus Berndt
- Christian A. HudertCHChristian A. Hudert
- Johannes EcksteinJEJohannes Eckstein
- Christoph LoddenkemperCLChristoph Loddenkemper
- Stephan HenningSHStephan Henning
- Philip BuflerPBPhilip Bufler
- David MeierhoferDavid Meierhofer
- Ingolf SackISIngolf Sack
- Susanna WiegandSWSusanna Wiegand
- Iwona WallachIWIwona Wallach
- Hermann-Georg HolzhütterHHHermann-Georg Holzhütter
Open Access
- 21 September 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11072
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and is associated with overweight and insulin resistance (IR). Almost nothing is known about in vivo alterations of liver metabolism in NAFLD, especially in the early stages of non-alcoholic steatohepatitis (NASH). Here, we used a complex mathematical model of liver metabolism to quantify the central hepatic metabolic functions of 71 children with biopsy-proven NAFLD. For each patient, a personalized model variant was generated based on enzyme abundances determined by mass spectroscopy. Our analysis revealed statistically significant alterations in the hepatic carbohydrate, lipid, and ammonia metabolism, which increased with the degree of obesity and severity of NAFLD. Histologic features of NASH and IR displayed opposing associations with changes in carbohydrate and lipid metabolism but synergistically decreased urea synthesis in favor of the increased release of glutamine, a driver of liver fibrosis. Taken together, our study reveals already significant alterations in the NASH liver of pediatric patients, which, however, are differently modulated by the simultaneous presence of IR.Keywords
Funding Information
- German Federal Ministry of Education and Research (31L0057, 031L0058, 031L0258H)
- Max Planck Society (31L0057, 031L0058, 031L0258H)
This publication has 46 references indexed in Scilit:
- Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose MetabolismPLOS Computational Biology, 2012
- The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humansJournal of Clinical Investigation, 2012
- Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16 390 overweight or obese children and adolescentsInternational Journal of Obesity, 2010
- Body mass index percentiles for children and adolescents in Germany based on a nationally representative sample (KiGGS 2003–2006)European Journal of Clinical Nutrition, 2010
- Inflammatory Mediators of Hepatic SteatosisMediators of Inflammation, 2010
- Glucose dysregulation and hepatic steatosis in obese adolescentsHepatology, 2009
- Prevalence of Fatty Liver in Children and AdolescentsPediatrics, 2006
- Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptorBiochemical Journal, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUSThe Lancet, 1963